Changes

no edit summary
Line 33: Line 33:     
=== Examples of disclosure of interest forms: ===
 
=== Examples of disclosure of interest forms: ===
* [[Images/b/b2/PHAC DOI form 11Sept2020 v9.0.docx|[IN DEVELOPMENT] PHAC Dislosure of Interest Form (last updated Sept 11, 2020)]]
+
* [[Images/b/b2/PHAC DOI form 11Sept2020 v9.0.docx|(IN DEVELOPMENT) PHAC Dislosure of Interest Form (last updated Sept 11, 2020)]]
 
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i12 American Thoracic Society disclosure of interests form]
 
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i12 American Thoracic Society disclosure of interests form]
 
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines-form.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for panel members]
 
* [https://www.cadth.ca/sites/default/files/pcodr/pCODR%27s Drug Review Process/pcodr-coi-guidelines-form.docx CADTH pan-Canadian Oncology Drug Review disclosure of interest form for panel members]
Line 60: Line 60:     
=== Examples of scales for assessing the significance of COI ===
 
=== Examples of scales for assessing the significance of COI ===
* [[Images/4/4d/PHAC COI Tool 19Aug2020.xlsx|[IN DEVELOPMENT] PHAC COI Assessment Tool (last updated Aug 19, 2020)]]
+
* [[Images/4/4d/PHAC COI Tool 19Aug2020.xlsx|(IN DEVELOPMENT) PHAC COI Assessment Tool (last updated Aug 19, 2020)]]
 
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i13 American Thoracic Society method for evaluating significance of COI]
 
* [https://www.atsjournals.org/doi/full/10.1164/rccm.200901-0126ST#_i13 American Thoracic Society method for evaluating significance of COI]
 
* [https://www.who.int/publications/guidelines/handbook_2nd_ed.pdf World Health Organization criteria for assessing the severity of a conflict of interest] (see p. 78)
 
* [https://www.who.int/publications/guidelines/handbook_2nd_ed.pdf World Health Organization criteria for assessing the severity of a conflict of interest] (see p. 78)